Phenylephrine + Homatropine HydrobromideThird Party Manufacturing in India

Phenylephrine + Homatropine Hydrobromide works through a dual mechanism to achieve profound pupillary dilation and ciliary muscle relaxation. Phenylephrine directly stimulates alpha-1 adrenergic receptors to contract the iris dilator muscle. Simultaneously, Homatropine Hydrobromide acts as a competitive antagonist at muscarinic acetylcholine receptors, blocking the parasympathetic constriction impulses of the sphincter pupillae and inhibiting the ciliary muscle to cause cycloplegia. Unlike single-agent solutions, this combination provides a predictable, stable mydriatic effect that resists constriction during bright-light surgical procedures while temporarily immobilizing inflamed internal ocular tissues. It is highly effective and well-tolerated.

Therapeutic Uses

• Pre-Operative Mydriasis: Prepares the eye for intraocular procedures including cataract extractions and retinal repairs.
• Cycloplegic Refraction: Temporarily paralyzes accommodation to ensure accurate measurement of refractive errors in pediatric or non-cooperative patients.
• Ciliary Spasm Alleviation: Immobilizes inflamed intraocular structures to reduce deep structural pain associated with acute iridocyclitis.

Why Manufacturers Choose Phenylephrine + Homatropine Hydrobromide

This specialized formulation is vital for surgical ophthalmology centers and diagnostic clinics worldwide. Producing this stable combination requires strict quality checks on raw material grades, verified CAS numbers, and rigorous testing for particle size distribution in liquid matrices. Partnering with Celesta for Phenylephrine + Homatropine Hydrobromide third party manufacturing in India connects you with WHO-GMP compliant facilities capable of delivering world-class, premium ophthalmic products to scale your business.